Source link : https://www.newshealth.biz/health-news/fda-approves-ustekinumab-biosimilar-otulfi/
The US Food and Drug Administration has approved ustekinumab-aauz (Otulfi), a biosimilar that references Johnson & Johnson’s ustekinumab (Stelara). This is the fourth ustekinumab biosimilar approved in the United States. Like the reference product, ustekinumab-aauz is indicated for: Patients 6 years or older with moderate to severe plaque psoriasis who are candidates for phototherapy or […]
Author : News Health
Publish date : 2024-10-01 18:48:29
Copyright for syndicated content belongs to the linked Source.
Categories